Related Experiment Video

Updated: Dec 9, 2025

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.5K

Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia

Céline Luquain-Costaz1, Maaike Kockx2, Malcolm Anastasius2

  • 1INSERM U1060, Carmen laboratory, INSA de Lyon, Villeurbanne, France (C.L.-C.).

Insights

Patients with schizophrenia show altered cholesterol transport, with higher HDL cholesterol efflux capacity despite lower HDL levels. This suggests a complex cardiovascular risk profile in schizophrenia, emphasizing atherogenic lipoprotein reduction.

Area of Science:

  • Cardiovascular Disease Research
  • Metabolic Disorders
  • Neuropsychiatric Disorders

Background:

  • Schizophrenia is linked to increased cardiovascular mortality and dyslipidemia, including low high-density lipoprotein cholesterol (HDL-C).
  • High-density lipoprotein (HDL) cholesterol efflux capacity (CEC) is a key measure of HDL function and a predictor of cardiovascular risk.
  • The impact of schizophrenia on HDL function, specifically CEC, remains largely unknown.

Purpose of the Study:

  • To investigate HDL cholesterol efflux capacity (CEC) in patients with schizophrenia compared to healthy controls.
  • To examine the relationship between CEC, lipoprotein subclasses, and clinical parameters in schizophrenia.

Main Methods:

  • Measured basal, ATP-binding cassette transporter A1 (ABCA1)-dependent, and ABCG1-dependent CEC in 120 patients with schizophrenia and 51 healthy controls.
  • Utilized nuclear magnetic resonance (NMR) analysis for lipoprotein subclass profiling.
  • Correlated CEC findings with lipid profiles and apolipoprotein concentrations.

Main Results:

  • Patients with schizophrenia exhibited lower HDL-C and apolipoprotein A-I but higher triglycerides and atherogenic lipoproteins.
  • Despite lower HDL-C, basal and ABCA1-dependent CEC were significantly higher in patients with schizophrenia.
  • ABCA1-specific efflux correlated with small HDL particle abundance in schizophrenia patients.

Conclusions:

  • Schizophrenia is associated with enhanced ABCA1-mediated cholesterol efflux capacity, despite dyslipidemia and reduced large HDL particles.
  • Preventative cardiovascular strategies in schizophrenia should prioritize reducing atherogenic lipoproteins over solely increasing CEC.
Abstract

Related Concept Videos

Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
352
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.6K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
356
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
226
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.1K
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
294